These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6348929)

  • 1. [Construction of a survival curve].
    Hill C; Benhamou E; Rey A
    Rev Prat; 1983 Apr; 33(21):1041-50. PubMed ID: 6348929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of 2 survival curves].
    Hill C; Benhamou E; Rey A
    Rev Prat; 1983 Apr; 33(21):1059-60, 1065-6. PubMed ID: 6348930
    [No Abstract]   [Full Text] [Related]  

  • 3. Pitfalls of inferring annual mortality from inspection of published survival curves.
    Singer RB
    J Insur Med; 1994; 26(3):333-8. PubMed ID: 10150509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On clinical trials and survival analysis.
    Lee HP
    Singapore Med J; 1982 Jun; 23(3):164-7. PubMed ID: 7146921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Actuarial survival].
    Jacquillat CL; Hucher M
    Nouv Presse Med; 1981 Apr; 10(18):1459-60. PubMed ID: 7255117
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic situation of hepatitis B in immigrants. Strategy for vaccination].
    Romea Lecumberri S; Durán Pla E; Cabezos Otón J; Bada Aínsa JL
    Med Clin (Barc); 1997 Nov; 109(17):656-60. PubMed ID: 9488953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
    Romanò L; Paladini S; Tagliacarne C; Zappa A; Zanetti AR
    Vaccine; 2009 May; 27(25-26):3439-42. PubMed ID: 19200848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical analysis of survival data.
    Crowley J; Breslow N
    Annu Rev Public Health; 1984; 5():385-411. PubMed ID: 6372816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of mortality ratios to a numerical rating classification for life insurance underwriting-revisited.
    Singer RB
    J Insur Med; 2004; 36(3):228-33. PubMed ID: 15495438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quicker method for calculating mortality ratios based on survival rates in clinical trials and other follow-up studies.
    Naslafkih A; Sestier F
    J Insur Med; 2001; 33(4):339-48. PubMed ID: 11877914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination against Hepatitis B: 20 years later].
    Vildozola H
    Rev Gastroenterol Peru; 2007; 27(1):57-66. PubMed ID: 17431429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social-cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men.
    de Wit JB; Vet R; Schutten M; van Steenbergen J
    Prev Med; 2005 Jun; 40(6):795-802. PubMed ID: 15850881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 'quick hit' method to assess insurance mortality from a clinical article.
    Iacovino JR
    J Insur Med; 1994; 26(3):317-8. PubMed ID: 10150506
    [No Abstract]   [Full Text] [Related]  

  • 16. Odds and ends.
    Kita MW
    J Insur Med; 1994; 26(3):339-46. PubMed ID: 10150510
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccination against hepatitis B. Review and prospects].
    Burette A
    Rev Med Brux; 1984 Jun; 5(6):373-83. PubMed ID: 6385192
    [No Abstract]   [Full Text] [Related]  

  • 18. Pivot tables for mortality analysis, or who needs life tables anyway?
    Wesley D; Cox HF
    J Insur Med; 2007; 39(3):167-73. PubMed ID: 18251375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q.ed.
    Kita MW; Labbe MJ
    J Insur Med; 1994; 26(3):303-12. PubMed ID: 10150504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.